Carbachol-induced reverse transformation of Chinese hamster ovary cells transfected with and expressing the m5 muscarinic acetylcholine receptor  by Felder, Christian C. et al.
Volume 245, number 1,2, 75-79 FEB 06888 March 1989 
Carbachol-induced reverse transformation of Chinese hamster 
ovary cells transfected with and expressing the m5 muscarinic 
acetylcholine receptor 
Christian C. Felder, Alice L. Ma and Bruce R. Conklin 
National Institute of Mental Health, Section on Pharmacology, Laboratory of Cell Biology, Bethesda, MD 20892, USA 
Received 22 December 1988; revised version received 13 January 1989 
Reverse transformation was induced in Chinese hamster ovary (CHO) cells transfected with and stably expressing the 
m5 subtype of the muscarinic acetylcholine r ceptor when stimulated with the muscarinic agonist, carbachol. Atropine, 
a muscarinic antagonist, blocked the carbachol-stimulated r verse transformation. CHO cells not ransfected with the 
muscarinic receptor did not change with added carbachol. PMA induced reverse transformation without increasing 
CAMP accumulation i  CHO cells. Carbachol, prostaglandin E,, and cholecystokinin increased CAMP accumulation but 
only carbachol caused reverse transformation. Carbachol-stimulated CAMP accumulation occurred at a higher concen- 
tration (EC, 10 PM) than did carbachol-stimulated reverse transformation (EC, 63 nM). Muscarinic m5 acetylcholine 
receptor transfected into CHO cells can induce reverse transformation which may be independent of CAMP. 
Muscarinic acetylcholine receptor; Reverse transformation; Phorbol ester; (CHO cell) 
1. INTRODUCTION 
Chinese hamster ovary (CHO) cells have been 
shown to lose their malignant characteristics and 
revert back to more normal fibroblast-like mor- 
phology and growth properties when stimulated 
with Z@,& ’ -dibutyryl-CAMP [l] and cholera toxin 
[2]. This reverse transformation is accompanied by 
changes in cell surface features, cytoskeletal 
organization, growth characteristics, and DNA 
hypersensitivity to nuclease action [3,4]. Although 
cholera toxin and CAMP induce morphological 
changes in CHO cells, these changes have not been 
shown to be mediated through stimulation of a cell 
surface receptor. 
We have used CHO cells transfected with and 
stably expressing the m5 subtype of the muscarinic 
acetylcholine receptor to determine whether mor- 
phological changes could be seen upon receptor ac- 
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tivation. We report that stimulation of the 
muscarinic m5 acetylcholine receptor transfected 
into CHO cells can induce reverse transformation. 
In these cells, the m5 receptor is linked to increases 
in CAMP and release of inositol phosphates [5], 
either of which could be involved in the mechanism 
of reverse transformation. We suggest that reverse 
transformation may be induced by a mechanism 
independent of CAMP. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phorbol IZmyristate 13-acetate (PMA) was purchased from 
Calbiochem (La Jolla, CA). 4o-Phorbol 12-myristate 13-acetate 
(4oPMA) was purchased from Biomol (Plymouth Meeting, 
PA). Reagents for the radioimmunoassay of CAMP were sup- 
plied by Dr Gary Brooker (Georgetown University, 
Washington, DC). All other reagents were purchased from 
Sigma (St. Louis, MO). 
2.2. Cell culture of CHO cells 
CHO cells were maintained in alpha modified Eagle’s 
medium with 10% newborn calf serum (MA Bioproducts, 
Walkersville, MD) at 37”C, under an atmosphere of Y7o COZ, 
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in plastic petri dishes. CHO cells stably expressing the 
transfected muscarinic m5 acetylcholine receptor [5] were 
generously supplied by Drs Mark R. Brann and Noel J. 
Buckley. The lack of change in basal or carbachol-stimulated 
levels of CAMP accumulation or inositol phospholipid turnover 
over the duration of this study suggested stable expression of 
the m5 muscarinic receptor. CHO cells were subcultured into 
plastic 6-well clusters (34 mm diameter) using 0.5% trypsin to 
remove cells from the plastic surface. Morphological transfor- 
mation (reverse transformation) was observed while cells were 
grown in alpha modified Eagle’s media as described above ex- 
cept that the ‘media contained only 1% newborn calf serum. 
2.3. Measurement of reverse transformation 
Cells were photographed at 800 x magnification with a den- 
sity of approx. 25 cells per field. The ratios of length to width 
of the cells were calculated for 10 cells randomly selected from 
the field. Broken or superimposed cells were excluded from 
measurement. 
2.4. Measurement of CAMP accumulation 
CHO cells were plated in plastic 24-well clusters at a density 
of 1 x lo6 cells per well and grown to confluence. The growth 
medium was replaced with 250 ,uI serum-free media containing 
the experimental agents to be tested and 1 mM IBMX. The 
reaction was stopped at the times indicated with 250 pl ice-cold 
solution containing 0.1 N HCl and 1 mM CaCl2. The ac- 
cumulation of CAMP was measured by radioimmunoassay as 
described [a]. No CAMP accumulation was observed in the 
absence of IBMX. 
3. RESULTS 
Carbachol, a muscarinic receptor agonist, 
caused reverse transformation in CHO cells stably 
expressing the transfected m5 receptor in a similar 
manner (fig.1) to that described by Hsie and Puck 
[7] using dibutyryl CAMP. The cells elongated to 
about twice their width and lined up in a parallel 
pattern resembling typical fibroblasts. In the 
absence of carbachol the cells were compact, well 
separated, and lacked defined orientation (fig. 1). 
The carbachol-induced change was concentration 
Fig. 1. Carbachol- and PMA-induced reverse transformation in CHO cells transfected with and stably expressing the muscarinic m5 
receptor. CHO cells transfected with the muscarinic m5 receptor were grown in continuous culture, stimulated with carbachol 
(10m4 M), carbachol (10v4 M) + atropine (10-s M), or PMA (lo-* M) as indicated for 24 h. Panels were randomly selected and are 
representative fields. 
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dependent (EC50 63 nM) and was blocked by the 
addition of a saturating dose of atropine (lo-’ M), 
a muscarinic receptor antagonist (figs 1,2), sug- 
gesting that the morphological change was 
associated with the stimulation of a membrane- 
bound receptor. Cells, which were not transfected 
with the m5 muscarinic receptor, did not undergo 
reverse transformation when treated with car- 
bachol (10m4 M), further suggesting that the 
change was due to the presence of the muscarinic 
receptor (table 1). The reverse transformation in- 
duced by carbachol had the same appearance as 
that induced by dibutyryl CAMP (lOA M), 
Gbromo CAMP (low4 M), and cholera toxin 
(100 ng/ml) measured at 24 h (not shown). 
Butyrate is therefore probably not involved in 
stimulating reverse transformation. 
Carbachol stimulates CAMP accumulation and 
inositol phospholipid turnover in CHO cells 
transfected with the m5 receptor [5]. Either of 
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Fig.2. Carbachol-stimulated CAMP accumulation, and 
carbachol- and PMA-stimulated reverse transformation in 
CHO cells transfected with and stably expressing the muscarinic 
m5 receptor. (Left axis and solid lines) Reverse transformation 
measured as the ratio of cell length/width was stimulated in 
CHO cells transfected with the muscarinic m5 receptor by PMA 
and the muscarinic agonist carbachol which was blocked by the 
muscarinic antagonist atropine (lo-’ M). Each point is the 
mean k SE cell ratio of four experiments (n = 10 cells per 
experiment). Cell ratios at 10-s M carbachol or greater were 
significantly different from basal ratios @ < 0.01 ANOVA, 
Dunnett’s test). Cells treated with atropine were not 
significantly different from basal ratios @ < 0.01 ANOVA, 
Dunnett’s test). PMA at 10-‘“-10-7 M was significantly 
different from basal cell ratios @ c 0.01 ANOVA, Dunnett’s 
test). (Right axis and dotted line) CAMP accumulation 
stimulated over 5 min by carbachol as described in section 2. 
Concentrations of carbachol above lo-’ M were significantly 
different from basal levels (basal value same as level at 10e9 M) 
@ < 0.01 ANOVA, Dunnett’s test). 
Table 1 
Length/width ratios and CAMP accumulation in control and 
m5 receptor-transfected CHO cells 
Cells L/W ratio 
mS-transfected CHO (CAMP pmol/ml 
cells (24 h)) 
Basal 13.1 -c 0.3 2.5 * 0.2 
Prostaglandin E2 
(lo-’ M) 1.5 f 0.3” 2.5 f 0.2 
Cholecystokinin 
(1O-6 M) 21.8 + 0.6& 2.6 f 0.3 
PMA (1O-8 M) 12.6 rt 0.6 4.1 * 0.3a 
Carbachol (10e4 M) 31.2 + 1.2a 4.3 * 0.3& 
Control CHO cells (CAMP pmol/ml 
(5 min)) 
Basal 12.3 rt 0.3 2.9 f 0.6 
Carbachol (10m4 M) 13.3 f 0.5 3.0 + 0.5 
a p < 0.01 vs basal levels ANOVA (Dunnett’s test) 
Reverse transformation was measured in CHO cells which were 
incubated with agonists for 24 h as described in the text. Data 
are the mean length/width ratios f SE measured on 10 cells per 
experiment for four experiments. CAMP in transfected cells was 
measured after 24 h under idential conditions in the presence of 
1 mM IBMX and is the mean f SE of three experiments 
performed in triplicate. CAMP was measured at 5 min in 
control cells 
these second messenger systems could be involved 
in the initiation of reverse transformation. 
Carbachol-stimulated CAMP accumulation at 
5 min occurred at a higher concentration (E& 
10 ,uM) than did carbachol-stimulated reverse 
transformation measured at 24 h (EC50 63 nM) 
(fig.2). PMA, which stimulates protein kinase C, 
also caused concentration-dependent reverse 
transformation (figs 1,2). PMA demonstrated 
decreased stimulation above 100 nM. The inactive 
4cu isomer of PMA at lo-* M did not cause reverse 
transformation (not shown). 
The time course of CAMP accumulation for car- 
bachol, cholecystokinin, prostaglandin EZ and 
PMA was measured in the presence of IBMX 
(fig.3, table 1). Carbachol stimulated CAMP ac- 
cumulation above basal levels which plateaued at 
30 min and was elevated l-fold over basal levels at 
24 h. PMA did not increase CAMP accumulation 
over basal levels up to 24 h, suggesting an alter- 
native mechanism to increases in intracellular 
CAMP for reverse transformation. This was fur- 
ther substantiated when prostaglandin E2 and 
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Fig.3. Time course of CAMP accumulation in CHO cells 
transfected with and stably expressing the muscarinic m5 
receptor. CHO cells transfected with the muscarinic m5 
receptor were grown in continuous culture, stimulated with 
carbachol (10e4 M), cholecystokinin (CCK) (10e6 M), 
prostaglandin E2 (PGEs) (lo-’ M), and PMA (lo-* M) for the 
times indicated. Data are means + SE of 3 experiments 
performed in triplicate. 
cholecystokinin increased CAMP accumulation but 
failed to induce reverse transformation. 
Cholecystokinin increased and prostaglandin Ez 
decreased CAMP accumulation at 24 h. 
4. DISCUSSION 
Our studies showed that carbachol stimulated 
reverse transformation in CHO cells transfected 
with the m5 subtype of the muscarinic 
acetylcholine receptor but not in cells lacking the 
receptor. The carbachol-stimulated reverse 
transformation was blocked with atropine, further 
suggesting that it was initiated through the activa- 
tion of a membrane receptor. 
Previous studies have demonstrated that reverse 
transformation in CHO cells is associated with in- 
creases in intracellular CAMP. Hsie and Puck [7] 
stimulated reverse transformation with dibutyryl 
CAMP which was enhanced with testosterone. The 
enterotoxins of Vibrio cholerae, Escherichia coli 
and Salmonella increased intracellular CAMP and 
also induced reverse transformation [8]. In our 
studies, carbachol stimulated CAMP accumulation 
and induced reverse transformation. Cholecysto- 
kinin and prostaglandin EZ also stimulated CAMP 
accumulation but did not induce reverse transfor- 
mation. It is unlikely that carbachol-stimulated 
CAMP induced the reverse transformation, since 
carbachol can stimulate reverse transformation at 
a concentration that has no apparent effect on 
CAMP. Carbachol maximally stimulated CAMP 
levels above basal levels at 5 min and declined to 
l-fold above basal levels at 24 h. It is also unlikely 
that this elevation of CAMP levels at 24 h is suffi- 
cient to induce reverse transformation, since 
cholecystokinin-stimulated CAMP accumulation 
was also elevated at 24 h. It is possible that cholera 
toxin and dibutyryl CAMP induce a sustained or 
unusually high level of CAMP formation not possi- 
ble in a receptor-mediated system, which may be 
an alternative mechanism for the induction of 
reverse transformation. 
Increased intracellular CAMP levels upon addi- 
tion of dibutyryl CAMP and bacterial enterotoxins 
do not appear to be the only mechanism involved 
in reverse transformation. We have observed a 
reverse transformation with PMA similar to that 
seen with the addition of carbachol, yet PMA did 
not increase CAMP accumulation over basal levels. 
PMA has been shown to effect a multiplicity of 
cellular processes including stimulation of protein 
kinase C [9], inhibition of phospholipase C [lo] 
and stimulation of phospholipase A2 [l 11. We are 
currently investigating the mechanism of PMA- 
induced reverse transformation and its relationship 
to the muscarinic acetylcholine receptor-induced 
reverse transformation. Of the five muscarinic 
receptor subtypes now cloned, ml, m3, and m5 are 
biochemically similar in that they couple to in- 
creases in CAMP accumulation and inositol 
phospholipid turnover, whereas m2 is coupled to 
inhibition of CAMP accumulation [5,12- 141. In in- 
itial studies, carbachol-stimulated ml and m3 
muscarinic receptors transfected into CHO cells in- 
duced a reverse transformation similar to that in- 
duced by m5. This suggests a common 
transduction pathway for the induction of reverse 
transformation in the CHO cell which has yet to be 
clarified. 
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